quinupristin/dalfopristin will boost the amount or impact of lemborexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Steer clear of coadministration of lemborexant with reasonable or potent CYP3A inhibitors. quinupristin/dalfopristin will enhance the